Salīdzināt metodes

	TED-QoL / GO-QoL: Vairogdziedzera radzenes slimību dzīves kvalitātes anketēšana	ThyPRO: Pacientu ziņoto iznākumu skala, kas saistīta ar vairogdziedzeri
Nozare	Endokrinoloģija	Endokrinoloģija
Saime	Process / pipeline	Process / pipeline
Izcelsmes gads	2001	2009
Autors	Caroline Terwee, Markus Gerding, Frank Dekker	Torquil Watt, Jens Bjørner, Marianne Groenvold
Tips	Patient self-report questionnaire	Patient self-report questionnaire
Pirmavots	Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779.	Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580.
Citi nosaukumi	GO-QoL, Graves Ophthalmopathy Quality of Life	ThyPRO-85, ThyPRO-39
Saistītās	3	3
Kopsavilkums	The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment.	ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer.